European drugmakers say they are ‘losing ground’ to US and Chinese rivals
Leading European pharmaceutical companies have written to government officials across the continent, warning that they are falling behind competitors from the United States and China. The letters request coordinated policy measures, investment support, and regulatory reforms to preserve the industry's competitiveness and secure jobs. Executives argue that without intervention, Europe's drug sector could lose market share and innovation capacity.